Glycopyrronium Wolff

Glycopyrronium Wolff is a prescription‑only topical product that contains glycopyrronium bromide as its active ingredient. It is marketed in the European Union and is classified as an anticholinergic (muscarinic antagonist) used to reduce excessive sweating. The formulation is applied directly to the skin, where it competitively blocks muscarinic receptors in sweat glands, thereby decreasing sweat production in patients with hyperhidrosis.

Glycopyrronium Wolff is indicated for the management of primary hyperhidrosis, a condition characterized by excessive sweating that is not caused by another medical disorder. It is commonly prescribed for localized areas where sweating is problematic.

- Treatment of primary axillary hyperhidrosis (under‑arm sweating) - Management of palmar hyperhidrosis (excessive hand sweating) - Relief of plantar hyperhidrosis (excessive foot sweating) - Adjunct therapy for facial or scalp hyperhidrosis when other measures are insufficient - Use as part of a comprehensive hyperhidrosis treatment plan that may include lifestyle modifications

Side effects of Glycopyrronium Wolff are generally related to its anticholinergic activity on the skin and surrounding tissues.

Common: - Mild skin irritation or erythema at the application site - Dryness of the treated skin area - Tingling or pruritus (itching) where the product is applied - Transient burning sensation after application - Temporary reduction in local sweating leading to a feeling of coolness

Serious: - Severe allergic reaction (e.g., angioedema, urticaria) - Persistent or worsening skin ulceration - Systemic anticholinergic effects such as blurred vision, dry mouth, or urinary retention (rare) - Contact dermatitis requiring medical intervention - Unexplained fever or systemic symptoms after use

Before using Glycopyrronium Wolff, certain precautions should be considered to ensure safe and effective treatment.

- Confirm diagnosis of primary hyperhidrosis and rule out secondary causes before initiating therapy - Avoid application on broken, inflamed, or infected skin - Use the product only as prescribed; do not exceed the recommended application area or frequency - Patients with known hypersensitivity to glycopyrronium bromide or any excipients should not use this medication - Caution in patients with glaucoma, urinary retention, or gastrointestinal obstruction due to potential systemic anticholinergic absorption - Pregnant or breastfeeding individuals should discuss potential risks with a healthcare professional - Store at room temperature, protected from moisture and direct sunlight

Glycopyrronium Wolff may interact with other substances that affect anticholinergic activity or skin absorption.

Avoid: - Concurrent use of other topical anticholinergic agents on the same area, which could increase systemic exposure - Application of strong irritant or corrosive topical products (e.g., chemical peels) immediately before or after using Glycopyrronium Wolff

Use with caution: - Systemic anticholinergic medications (e.g., antihistamines, tricyclic antidepressants) that may potentiate anticholinergic side effects - Topical corticosteroids, which could alter skin barrier and affect drug absorption - Occlusive dressings that increase drug penetration and risk of systemic effects - Herbal or over‑the‑counter products containing anticholinergic compounds